$14.4 - FULC | Fulcrum Therapeutics, Inc. Common Stock

Fulcrum Therapeutics, Inc. Common Stock (FULC)

Fulcrum Therapeutics, Inc. Common Stock

XNAS:FULC

14.4

61.80%

Ask

$14.47 - 47.00

Bid

$14.38 - 248.00

Low

$12.74

High

$15.74

Open

$12.92

Prev Close

$8.9

52W High

15.74

52W Low

2.32

Volume

20390335

Avg Vol (3m)

721736.9

Float

48003832.58

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 07/18/2019

Primary Exchange: XNAS

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Phone: 617-651-8851

Address: 26 Landsdowne Street

City: Cambridge

State: MA

Postal Code: 02139

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-7.550000

P/B (TTM)

2.427660

Round Lot

100

Composit FIGI

BBG00DDY1RK9

Share Class FIGI

BBG00DDY1RM7

Share Class Shares Outstanding

54.09M

Weighted Shares Outstanding

54.12M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion